SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-166863
Filing Date
2023-06-14
Accepted
2023-06-14 16:11:03
Documents
18
Period of Report
2023-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d484657d8k.htm   iXBRL 8-K 35250
2 EX-5.1 d484657dex51.htm EX-5.1 6401
3 EX-10.1 d484657dex101.htm EX-10.1 195230
4 EX-10.2 d484657dex102.htm EX-10.2 99277
5 EX-99.1 d484657dex991.htm EX-99.1 9845
9 GRAPHIC g484657g0613053437854.jpg GRAPHIC 2322
10 GRAPHIC g484657page1.jpg GRAPHIC 11237
  Complete submission text file 0001193125-23-166863.txt   582111

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bior-20230612.xsd EX-101.SCH 2869
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20230612_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20230612_pre.xml EX-101.PRE 11720
12 EXTRACTED XBRL INSTANCE DOCUMENT d484657d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 231014216
SIC: 2834 Pharmaceutical Preparations